Global Intermediate CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Intermediate CDMO market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Intermediate CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intermediate CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Intermediate CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Intermediate CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Intermediate CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intermediate CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intermediate CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pharmira, AGC Inc, Blue Jet Healthcare, Drug Discovery Alliances and KriSan Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Intermediate CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Intermediate CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Intermediate CDMO, with revenue, gross margin and global market share of Intermediate CDMO from 2018 to 2023.
Chapter 3, the Intermediate CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Intermediate CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Intermediate CDMO.
Chapter 13, to describe Intermediate CDMO research findings and conclusion.
This report is a detailed and comprehensive analysis for global Intermediate CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intermediate CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Intermediate CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Intermediate CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Intermediate CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intermediate CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intermediate CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pharmira, AGC Inc, Blue Jet Healthcare, Drug Discovery Alliances and KriSan Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Intermediate CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Antibiotic Intermediates
- Antipyretic and Analgesic Intermediate
- Cardiovascular System Drug Intermediates
- Anticancer Drug Intermediates
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
- Others
- Pharmira
- AGC Inc
- Blue Jet Healthcare
- Drug Discovery Alliances
- KriSan Biotech
- Saurav Chemicals
- Olon SpA
- AGC Biologics
- Fermion
- Pfizer CentreOne
- Aspen Holdings
- Educell
- Hovione
- Porton Pharma Solutions
- Sinopep
- Chongqing Huapont Pharmaceutical
- Langhua Pharmaceutical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Intermediate CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Intermediate CDMO, with revenue, gross margin and global market share of Intermediate CDMO from 2018 to 2023.
Chapter 3, the Intermediate CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Intermediate CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Intermediate CDMO.
Chapter 13, to describe Intermediate CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Intermediate CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Intermediate CDMO by Type
1.3.1 Overview: Global Intermediate CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Intermediate CDMO Consumption Value Market Share by Type in 2022
1.3.3 Antibiotic Intermediates
1.3.4 Antipyretic and Analgesic Intermediate
1.3.5 Cardiovascular System Drug Intermediates
1.3.6 Anticancer Drug Intermediates
1.4 Global Intermediate CDMO Market by Application
1.4.1 Overview: Global Intermediate CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.4.4 Generic Company
1.4.5 Others
1.5 Global Intermediate CDMO Market Size & Forecast
1.6 Global Intermediate CDMO Market Size and Forecast by Region
1.6.1 Global Intermediate CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Intermediate CDMO Market Size by Region, (2018-2029)
1.6.3 North America Intermediate CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Intermediate CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Intermediate CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Intermediate CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Intermediate CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pharmira
2.1.1 Pharmira Details
2.1.2 Pharmira Major Business
2.1.3 Pharmira Intermediate CDMO Product and Solutions
2.1.4 Pharmira Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pharmira Recent Developments and Future Plans
2.2 AGC Inc
2.2.1 AGC Inc Details
2.2.2 AGC Inc Major Business
2.2.3 AGC Inc Intermediate CDMO Product and Solutions
2.2.4 AGC Inc Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AGC Inc Recent Developments and Future Plans
2.3 Blue Jet Healthcare
2.3.1 Blue Jet Healthcare Details
2.3.2 Blue Jet Healthcare Major Business
2.3.3 Blue Jet Healthcare Intermediate CDMO Product and Solutions
2.3.4 Blue Jet Healthcare Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Blue Jet Healthcare Recent Developments and Future Plans
2.4 Drug Discovery Alliances
2.4.1 Drug Discovery Alliances Details
2.4.2 Drug Discovery Alliances Major Business
2.4.3 Drug Discovery Alliances Intermediate CDMO Product and Solutions
2.4.4 Drug Discovery Alliances Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Drug Discovery Alliances Recent Developments and Future Plans
2.5 KriSan Biotech
2.5.1 KriSan Biotech Details
2.5.2 KriSan Biotech Major Business
2.5.3 KriSan Biotech Intermediate CDMO Product and Solutions
2.5.4 KriSan Biotech Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 KriSan Biotech Recent Developments and Future Plans
2.6 Saurav Chemicals
2.6.1 Saurav Chemicals Details
2.6.2 Saurav Chemicals Major Business
2.6.3 Saurav Chemicals Intermediate CDMO Product and Solutions
2.6.4 Saurav Chemicals Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Saurav Chemicals Recent Developments and Future Plans
2.7 Olon SpA
2.7.1 Olon SpA Details
2.7.2 Olon SpA Major Business
2.7.3 Olon SpA Intermediate CDMO Product and Solutions
2.7.4 Olon SpA Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Olon SpA Recent Developments and Future Plans
2.8 AGC Biologics
2.8.1 AGC Biologics Details
2.8.2 AGC Biologics Major Business
2.8.3 AGC Biologics Intermediate CDMO Product and Solutions
2.8.4 AGC Biologics Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AGC Biologics Recent Developments and Future Plans
2.9 Fermion
2.9.1 Fermion Details
2.9.2 Fermion Major Business
2.9.3 Fermion Intermediate CDMO Product and Solutions
2.9.4 Fermion Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Fermion Recent Developments and Future Plans
2.10 Pfizer CentreOne
2.10.1 Pfizer CentreOne Details
2.10.2 Pfizer CentreOne Major Business
2.10.3 Pfizer CentreOne Intermediate CDMO Product and Solutions
2.10.4 Pfizer CentreOne Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer CentreOne Recent Developments and Future Plans
2.11 Aspen Holdings
2.11.1 Aspen Holdings Details
2.11.2 Aspen Holdings Major Business
2.11.3 Aspen Holdings Intermediate CDMO Product and Solutions
2.11.4 Aspen Holdings Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Aspen Holdings Recent Developments and Future Plans
2.12 Educell
2.12.1 Educell Details
2.12.2 Educell Major Business
2.12.3 Educell Intermediate CDMO Product and Solutions
2.12.4 Educell Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Educell Recent Developments and Future Plans
2.13 Hovione
2.13.1 Hovione Details
2.13.2 Hovione Major Business
2.13.3 Hovione Intermediate CDMO Product and Solutions
2.13.4 Hovione Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hovione Recent Developments and Future Plans
2.14 Porton Pharma Solutions
2.14.1 Porton Pharma Solutions Details
2.14.2 Porton Pharma Solutions Major Business
2.14.3 Porton Pharma Solutions Intermediate CDMO Product and Solutions
2.14.4 Porton Pharma Solutions Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Porton Pharma Solutions Recent Developments and Future Plans
2.15 Sinopep
2.15.1 Sinopep Details
2.15.2 Sinopep Major Business
2.15.3 Sinopep Intermediate CDMO Product and Solutions
2.15.4 Sinopep Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sinopep Recent Developments and Future Plans
2.16 Chongqing Huapont Pharmaceutical
2.16.1 Chongqing Huapont Pharmaceutical Details
2.16.2 Chongqing Huapont Pharmaceutical Major Business
2.16.3 Chongqing Huapont Pharmaceutical Intermediate CDMO Product and Solutions
2.16.4 Chongqing Huapont Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Chongqing Huapont Pharmaceutical Recent Developments and Future Plans
2.17 Langhua Pharmaceutical
2.17.1 Langhua Pharmaceutical Details
2.17.2 Langhua Pharmaceutical Major Business
2.17.3 Langhua Pharmaceutical Intermediate CDMO Product and Solutions
2.17.4 Langhua Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Langhua Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Intermediate CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Intermediate CDMO by Company Revenue
3.2.2 Top 3 Intermediate CDMO Players Market Share in 2022
3.2.3 Top 6 Intermediate CDMO Players Market Share in 2022
3.3 Intermediate CDMO Market: Overall Company Footprint Analysis
3.3.1 Intermediate CDMO Market: Region Footprint
3.3.2 Intermediate CDMO Market: Company Product Type Footprint
3.3.3 Intermediate CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Intermediate CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Intermediate CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Intermediate CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Intermediate CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Intermediate CDMO Consumption Value by Type (2018-2029)
6.2 North America Intermediate CDMO Consumption Value by Application (2018-2029)
6.3 North America Intermediate CDMO Market Size by Country
6.3.1 North America Intermediate CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Intermediate CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Intermediate CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Intermediate CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Intermediate CDMO Consumption Value by Type (2018-2029)
7.2 Europe Intermediate CDMO Consumption Value by Application (2018-2029)
7.3 Europe Intermediate CDMO Market Size by Country
7.3.1 Europe Intermediate CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Intermediate CDMO Market Size and Forecast (2018-2029)
7.3.3 France Intermediate CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Intermediate CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Intermediate CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Intermediate CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Intermediate CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Intermediate CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Intermediate CDMO Market Size by Region
8.3.1 Asia-Pacific Intermediate CDMO Consumption Value by Region (2018-2029)
8.3.2 China Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.5 India Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Intermediate CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Intermediate CDMO Consumption Value by Type (2018-2029)
9.2 South America Intermediate CDMO Consumption Value by Application (2018-2029)
9.3 South America Intermediate CDMO Market Size by Country
9.3.1 South America Intermediate CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Intermediate CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Intermediate CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Intermediate CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Intermediate CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Intermediate CDMO Market Size by Country
10.3.1 Middle East & Africa Intermediate CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Intermediate CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Intermediate CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Intermediate CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Intermediate CDMO Market Drivers
11.2 Intermediate CDMO Market Restraints
11.3 Intermediate CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Intermediate CDMO Industry Chain
12.2 Intermediate CDMO Upstream Analysis
12.3 Intermediate CDMO Midstream Analysis
12.4 Intermediate CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Intermediate CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Intermediate CDMO by Type
1.3.1 Overview: Global Intermediate CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Intermediate CDMO Consumption Value Market Share by Type in 2022
1.3.3 Antibiotic Intermediates
1.3.4 Antipyretic and Analgesic Intermediate
1.3.5 Cardiovascular System Drug Intermediates
1.3.6 Anticancer Drug Intermediates
1.4 Global Intermediate CDMO Market by Application
1.4.1 Overview: Global Intermediate CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.4.4 Generic Company
1.4.5 Others
1.5 Global Intermediate CDMO Market Size & Forecast
1.6 Global Intermediate CDMO Market Size and Forecast by Region
1.6.1 Global Intermediate CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Intermediate CDMO Market Size by Region, (2018-2029)
1.6.3 North America Intermediate CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Intermediate CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Intermediate CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Intermediate CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Intermediate CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pharmira
2.1.1 Pharmira Details
2.1.2 Pharmira Major Business
2.1.3 Pharmira Intermediate CDMO Product and Solutions
2.1.4 Pharmira Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pharmira Recent Developments and Future Plans
2.2 AGC Inc
2.2.1 AGC Inc Details
2.2.2 AGC Inc Major Business
2.2.3 AGC Inc Intermediate CDMO Product and Solutions
2.2.4 AGC Inc Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AGC Inc Recent Developments and Future Plans
2.3 Blue Jet Healthcare
2.3.1 Blue Jet Healthcare Details
2.3.2 Blue Jet Healthcare Major Business
2.3.3 Blue Jet Healthcare Intermediate CDMO Product and Solutions
2.3.4 Blue Jet Healthcare Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Blue Jet Healthcare Recent Developments and Future Plans
2.4 Drug Discovery Alliances
2.4.1 Drug Discovery Alliances Details
2.4.2 Drug Discovery Alliances Major Business
2.4.3 Drug Discovery Alliances Intermediate CDMO Product and Solutions
2.4.4 Drug Discovery Alliances Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Drug Discovery Alliances Recent Developments and Future Plans
2.5 KriSan Biotech
2.5.1 KriSan Biotech Details
2.5.2 KriSan Biotech Major Business
2.5.3 KriSan Biotech Intermediate CDMO Product and Solutions
2.5.4 KriSan Biotech Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 KriSan Biotech Recent Developments and Future Plans
2.6 Saurav Chemicals
2.6.1 Saurav Chemicals Details
2.6.2 Saurav Chemicals Major Business
2.6.3 Saurav Chemicals Intermediate CDMO Product and Solutions
2.6.4 Saurav Chemicals Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Saurav Chemicals Recent Developments and Future Plans
2.7 Olon SpA
2.7.1 Olon SpA Details
2.7.2 Olon SpA Major Business
2.7.3 Olon SpA Intermediate CDMO Product and Solutions
2.7.4 Olon SpA Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Olon SpA Recent Developments and Future Plans
2.8 AGC Biologics
2.8.1 AGC Biologics Details
2.8.2 AGC Biologics Major Business
2.8.3 AGC Biologics Intermediate CDMO Product and Solutions
2.8.4 AGC Biologics Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AGC Biologics Recent Developments and Future Plans
2.9 Fermion
2.9.1 Fermion Details
2.9.2 Fermion Major Business
2.9.3 Fermion Intermediate CDMO Product and Solutions
2.9.4 Fermion Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Fermion Recent Developments and Future Plans
2.10 Pfizer CentreOne
2.10.1 Pfizer CentreOne Details
2.10.2 Pfizer CentreOne Major Business
2.10.3 Pfizer CentreOne Intermediate CDMO Product and Solutions
2.10.4 Pfizer CentreOne Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer CentreOne Recent Developments and Future Plans
2.11 Aspen Holdings
2.11.1 Aspen Holdings Details
2.11.2 Aspen Holdings Major Business
2.11.3 Aspen Holdings Intermediate CDMO Product and Solutions
2.11.4 Aspen Holdings Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Aspen Holdings Recent Developments and Future Plans
2.12 Educell
2.12.1 Educell Details
2.12.2 Educell Major Business
2.12.3 Educell Intermediate CDMO Product and Solutions
2.12.4 Educell Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Educell Recent Developments and Future Plans
2.13 Hovione
2.13.1 Hovione Details
2.13.2 Hovione Major Business
2.13.3 Hovione Intermediate CDMO Product and Solutions
2.13.4 Hovione Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hovione Recent Developments and Future Plans
2.14 Porton Pharma Solutions
2.14.1 Porton Pharma Solutions Details
2.14.2 Porton Pharma Solutions Major Business
2.14.3 Porton Pharma Solutions Intermediate CDMO Product and Solutions
2.14.4 Porton Pharma Solutions Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Porton Pharma Solutions Recent Developments and Future Plans
2.15 Sinopep
2.15.1 Sinopep Details
2.15.2 Sinopep Major Business
2.15.3 Sinopep Intermediate CDMO Product and Solutions
2.15.4 Sinopep Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sinopep Recent Developments and Future Plans
2.16 Chongqing Huapont Pharmaceutical
2.16.1 Chongqing Huapont Pharmaceutical Details
2.16.2 Chongqing Huapont Pharmaceutical Major Business
2.16.3 Chongqing Huapont Pharmaceutical Intermediate CDMO Product and Solutions
2.16.4 Chongqing Huapont Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Chongqing Huapont Pharmaceutical Recent Developments and Future Plans
2.17 Langhua Pharmaceutical
2.17.1 Langhua Pharmaceutical Details
2.17.2 Langhua Pharmaceutical Major Business
2.17.3 Langhua Pharmaceutical Intermediate CDMO Product and Solutions
2.17.4 Langhua Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Langhua Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Intermediate CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Intermediate CDMO by Company Revenue
3.2.2 Top 3 Intermediate CDMO Players Market Share in 2022
3.2.3 Top 6 Intermediate CDMO Players Market Share in 2022
3.3 Intermediate CDMO Market: Overall Company Footprint Analysis
3.3.1 Intermediate CDMO Market: Region Footprint
3.3.2 Intermediate CDMO Market: Company Product Type Footprint
3.3.3 Intermediate CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Intermediate CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Intermediate CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Intermediate CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Intermediate CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Intermediate CDMO Consumption Value by Type (2018-2029)
6.2 North America Intermediate CDMO Consumption Value by Application (2018-2029)
6.3 North America Intermediate CDMO Market Size by Country
6.3.1 North America Intermediate CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Intermediate CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Intermediate CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Intermediate CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Intermediate CDMO Consumption Value by Type (2018-2029)
7.2 Europe Intermediate CDMO Consumption Value by Application (2018-2029)
7.3 Europe Intermediate CDMO Market Size by Country
7.3.1 Europe Intermediate CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Intermediate CDMO Market Size and Forecast (2018-2029)
7.3.3 France Intermediate CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Intermediate CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Intermediate CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Intermediate CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Intermediate CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Intermediate CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Intermediate CDMO Market Size by Region
8.3.1 Asia-Pacific Intermediate CDMO Consumption Value by Region (2018-2029)
8.3.2 China Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.5 India Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Intermediate CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Intermediate CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Intermediate CDMO Consumption Value by Type (2018-2029)
9.2 South America Intermediate CDMO Consumption Value by Application (2018-2029)
9.3 South America Intermediate CDMO Market Size by Country
9.3.1 South America Intermediate CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Intermediate CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Intermediate CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Intermediate CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Intermediate CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Intermediate CDMO Market Size by Country
10.3.1 Middle East & Africa Intermediate CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Intermediate CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Intermediate CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Intermediate CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Intermediate CDMO Market Drivers
11.2 Intermediate CDMO Market Restraints
11.3 Intermediate CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Intermediate CDMO Industry Chain
12.2 Intermediate CDMO Upstream Analysis
12.3 Intermediate CDMO Midstream Analysis
12.4 Intermediate CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Intermediate CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Intermediate CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Intermediate CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Intermediate CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pharmira Company Information, Head Office, and Major Competitors
Table 6. Pharmira Major Business
Table 7. Pharmira Intermediate CDMO Product and Solutions
Table 8. Pharmira Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pharmira Recent Developments and Future Plans
Table 10. AGC Inc Company Information, Head Office, and Major Competitors
Table 11. AGC Inc Major Business
Table 12. AGC Inc Intermediate CDMO Product and Solutions
Table 13. AGC Inc Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. AGC Inc Recent Developments and Future Plans
Table 15. Blue Jet Healthcare Company Information, Head Office, and Major Competitors
Table 16. Blue Jet Healthcare Major Business
Table 17. Blue Jet Healthcare Intermediate CDMO Product and Solutions
Table 18. Blue Jet Healthcare Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Blue Jet Healthcare Recent Developments and Future Plans
Table 20. Drug Discovery Alliances Company Information, Head Office, and Major Competitors
Table 21. Drug Discovery Alliances Major Business
Table 22. Drug Discovery Alliances Intermediate CDMO Product and Solutions
Table 23. Drug Discovery Alliances Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Drug Discovery Alliances Recent Developments and Future Plans
Table 25. KriSan Biotech Company Information, Head Office, and Major Competitors
Table 26. KriSan Biotech Major Business
Table 27. KriSan Biotech Intermediate CDMO Product and Solutions
Table 28. KriSan Biotech Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. KriSan Biotech Recent Developments and Future Plans
Table 30. Saurav Chemicals Company Information, Head Office, and Major Competitors
Table 31. Saurav Chemicals Major Business
Table 32. Saurav Chemicals Intermediate CDMO Product and Solutions
Table 33. Saurav Chemicals Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Saurav Chemicals Recent Developments and Future Plans
Table 35. Olon SpA Company Information, Head Office, and Major Competitors
Table 36. Olon SpA Major Business
Table 37. Olon SpA Intermediate CDMO Product and Solutions
Table 38. Olon SpA Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Olon SpA Recent Developments and Future Plans
Table 40. AGC Biologics Company Information, Head Office, and Major Competitors
Table 41. AGC Biologics Major Business
Table 42. AGC Biologics Intermediate CDMO Product and Solutions
Table 43. AGC Biologics Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. AGC Biologics Recent Developments and Future Plans
Table 45. Fermion Company Information, Head Office, and Major Competitors
Table 46. Fermion Major Business
Table 47. Fermion Intermediate CDMO Product and Solutions
Table 48. Fermion Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Fermion Recent Developments and Future Plans
Table 50. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 51. Pfizer CentreOne Major Business
Table 52. Pfizer CentreOne Intermediate CDMO Product and Solutions
Table 53. Pfizer CentreOne Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Pfizer CentreOne Recent Developments and Future Plans
Table 55. Aspen Holdings Company Information, Head Office, and Major Competitors
Table 56. Aspen Holdings Major Business
Table 57. Aspen Holdings Intermediate CDMO Product and Solutions
Table 58. Aspen Holdings Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Aspen Holdings Recent Developments and Future Plans
Table 60. Educell Company Information, Head Office, and Major Competitors
Table 61. Educell Major Business
Table 62. Educell Intermediate CDMO Product and Solutions
Table 63. Educell Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Educell Recent Developments and Future Plans
Table 65. Hovione Company Information, Head Office, and Major Competitors
Table 66. Hovione Major Business
Table 67. Hovione Intermediate CDMO Product and Solutions
Table 68. Hovione Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Hovione Recent Developments and Future Plans
Table 70. Porton Pharma Solutions Company Information, Head Office, and Major Competitors
Table 71. Porton Pharma Solutions Major Business
Table 72. Porton Pharma Solutions Intermediate CDMO Product and Solutions
Table 73. Porton Pharma Solutions Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Porton Pharma Solutions Recent Developments and Future Plans
Table 75. Sinopep Company Information, Head Office, and Major Competitors
Table 76. Sinopep Major Business
Table 77. Sinopep Intermediate CDMO Product and Solutions
Table 78. Sinopep Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Sinopep Recent Developments and Future Plans
Table 80. Chongqing Huapont Pharmaceutical Company Information, Head Office, and Major Competitors
Table 81. Chongqing Huapont Pharmaceutical Major Business
Table 82. Chongqing Huapont Pharmaceutical Intermediate CDMO Product and Solutions
Table 83. Chongqing Huapont Pharmaceutical Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Chongqing Huapont Pharmaceutical Recent Developments and Future Plans
Table 85. Langhua Pharmaceutical Company Information, Head Office, and Major Competitors
Table 86. Langhua Pharmaceutical Major Business
Table 87. Langhua Pharmaceutical Intermediate CDMO Product and Solutions
Table 88. Langhua Pharmaceutical Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Langhua Pharmaceutical Recent Developments and Future Plans
Table 90. Global Intermediate CDMO Revenue (USD Million) by Players (2018-2023)
Table 91. Global Intermediate CDMO Revenue Share by Players (2018-2023)
Table 92. Breakdown of Intermediate CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Intermediate CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Intermediate CDMO Players
Table 95. Intermediate CDMO Market: Company Product Type Footprint
Table 96. Intermediate CDMO Market: Company Product Application Footprint
Table 97. Intermediate CDMO New Market Entrants and Barriers to Market Entry
Table 98. Intermediate CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Intermediate CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Intermediate CDMO Consumption Value Share by Type (2018-2023)
Table 101. Global Intermediate CDMO Consumption Value Forecast by Type (2024-2029)
Table 102. Global Intermediate CDMO Consumption Value by Application (2018-2023)
Table 103. Global Intermediate CDMO Consumption Value Forecast by Application (2024-2029)
Table 104. North America Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Intermediate CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Intermediate CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Intermediate CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Intermediate CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Intermediate CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Intermediate CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Intermediate CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Intermediate CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Intermediate CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Intermediate CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Intermediate CDMO Raw Material
Table 135. Key Suppliers of Intermediate CDMO Raw Materials
Table 1. Global Intermediate CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Intermediate CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Intermediate CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Intermediate CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pharmira Company Information, Head Office, and Major Competitors
Table 6. Pharmira Major Business
Table 7. Pharmira Intermediate CDMO Product and Solutions
Table 8. Pharmira Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pharmira Recent Developments and Future Plans
Table 10. AGC Inc Company Information, Head Office, and Major Competitors
Table 11. AGC Inc Major Business
Table 12. AGC Inc Intermediate CDMO Product and Solutions
Table 13. AGC Inc Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. AGC Inc Recent Developments and Future Plans
Table 15. Blue Jet Healthcare Company Information, Head Office, and Major Competitors
Table 16. Blue Jet Healthcare Major Business
Table 17. Blue Jet Healthcare Intermediate CDMO Product and Solutions
Table 18. Blue Jet Healthcare Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Blue Jet Healthcare Recent Developments and Future Plans
Table 20. Drug Discovery Alliances Company Information, Head Office, and Major Competitors
Table 21. Drug Discovery Alliances Major Business
Table 22. Drug Discovery Alliances Intermediate CDMO Product and Solutions
Table 23. Drug Discovery Alliances Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Drug Discovery Alliances Recent Developments and Future Plans
Table 25. KriSan Biotech Company Information, Head Office, and Major Competitors
Table 26. KriSan Biotech Major Business
Table 27. KriSan Biotech Intermediate CDMO Product and Solutions
Table 28. KriSan Biotech Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. KriSan Biotech Recent Developments and Future Plans
Table 30. Saurav Chemicals Company Information, Head Office, and Major Competitors
Table 31. Saurav Chemicals Major Business
Table 32. Saurav Chemicals Intermediate CDMO Product and Solutions
Table 33. Saurav Chemicals Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Saurav Chemicals Recent Developments and Future Plans
Table 35. Olon SpA Company Information, Head Office, and Major Competitors
Table 36. Olon SpA Major Business
Table 37. Olon SpA Intermediate CDMO Product and Solutions
Table 38. Olon SpA Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Olon SpA Recent Developments and Future Plans
Table 40. AGC Biologics Company Information, Head Office, and Major Competitors
Table 41. AGC Biologics Major Business
Table 42. AGC Biologics Intermediate CDMO Product and Solutions
Table 43. AGC Biologics Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. AGC Biologics Recent Developments and Future Plans
Table 45. Fermion Company Information, Head Office, and Major Competitors
Table 46. Fermion Major Business
Table 47. Fermion Intermediate CDMO Product and Solutions
Table 48. Fermion Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Fermion Recent Developments and Future Plans
Table 50. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 51. Pfizer CentreOne Major Business
Table 52. Pfizer CentreOne Intermediate CDMO Product and Solutions
Table 53. Pfizer CentreOne Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Pfizer CentreOne Recent Developments and Future Plans
Table 55. Aspen Holdings Company Information, Head Office, and Major Competitors
Table 56. Aspen Holdings Major Business
Table 57. Aspen Holdings Intermediate CDMO Product and Solutions
Table 58. Aspen Holdings Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Aspen Holdings Recent Developments and Future Plans
Table 60. Educell Company Information, Head Office, and Major Competitors
Table 61. Educell Major Business
Table 62. Educell Intermediate CDMO Product and Solutions
Table 63. Educell Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Educell Recent Developments and Future Plans
Table 65. Hovione Company Information, Head Office, and Major Competitors
Table 66. Hovione Major Business
Table 67. Hovione Intermediate CDMO Product and Solutions
Table 68. Hovione Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Hovione Recent Developments and Future Plans
Table 70. Porton Pharma Solutions Company Information, Head Office, and Major Competitors
Table 71. Porton Pharma Solutions Major Business
Table 72. Porton Pharma Solutions Intermediate CDMO Product and Solutions
Table 73. Porton Pharma Solutions Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Porton Pharma Solutions Recent Developments and Future Plans
Table 75. Sinopep Company Information, Head Office, and Major Competitors
Table 76. Sinopep Major Business
Table 77. Sinopep Intermediate CDMO Product and Solutions
Table 78. Sinopep Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Sinopep Recent Developments and Future Plans
Table 80. Chongqing Huapont Pharmaceutical Company Information, Head Office, and Major Competitors
Table 81. Chongqing Huapont Pharmaceutical Major Business
Table 82. Chongqing Huapont Pharmaceutical Intermediate CDMO Product and Solutions
Table 83. Chongqing Huapont Pharmaceutical Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Chongqing Huapont Pharmaceutical Recent Developments and Future Plans
Table 85. Langhua Pharmaceutical Company Information, Head Office, and Major Competitors
Table 86. Langhua Pharmaceutical Major Business
Table 87. Langhua Pharmaceutical Intermediate CDMO Product and Solutions
Table 88. Langhua Pharmaceutical Intermediate CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Langhua Pharmaceutical Recent Developments and Future Plans
Table 90. Global Intermediate CDMO Revenue (USD Million) by Players (2018-2023)
Table 91. Global Intermediate CDMO Revenue Share by Players (2018-2023)
Table 92. Breakdown of Intermediate CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Intermediate CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Intermediate CDMO Players
Table 95. Intermediate CDMO Market: Company Product Type Footprint
Table 96. Intermediate CDMO Market: Company Product Application Footprint
Table 97. Intermediate CDMO New Market Entrants and Barriers to Market Entry
Table 98. Intermediate CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Intermediate CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Intermediate CDMO Consumption Value Share by Type (2018-2023)
Table 101. Global Intermediate CDMO Consumption Value Forecast by Type (2024-2029)
Table 102. Global Intermediate CDMO Consumption Value by Application (2018-2023)
Table 103. Global Intermediate CDMO Consumption Value Forecast by Application (2024-2029)
Table 104. North America Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Intermediate CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Intermediate CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Intermediate CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Intermediate CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Intermediate CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Intermediate CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Intermediate CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Intermediate CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Intermediate CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Intermediate CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Intermediate CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Intermediate CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Intermediate CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Intermediate CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Intermediate CDMO Raw Material
Table 135. Key Suppliers of Intermediate CDMO Raw Materials
LIST OF FIGURES
s
Figure 1. Intermediate CDMO Picture
Figure 2. Global Intermediate CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Intermediate CDMO Consumption Value Market Share by Type in 2022
Figure 4. Antibiotic Intermediates
Figure 5. Antipyretic and Analgesic Intermediate
Figure 6. Cardiovascular System Drug Intermediates
Figure 7. Anticancer Drug Intermediates
Figure 8. Global Intermediate CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Intermediate CDMO Consumption Value Market Share by Application in 2022
Figure 10. Pharmaceutical Company Picture
Figure 11. Biotechnology Company Picture
Figure 12. Generic Company Picture
Figure 13. Others Picture
Figure 14. Global Intermediate CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Intermediate CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Intermediate CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Intermediate CDMO Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Intermediate CDMO Consumption Value Market Share by Region in 2022
Figure 19. North America Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Intermediate CDMO Revenue Share by Players in 2022
Figure 25. Intermediate CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Intermediate CDMO Market Share in 2022
Figure 27. Global Top 6 Players Intermediate CDMO Market Share in 2022
Figure 28. Global Intermediate CDMO Consumption Value Share by Type (2018-2023)
Figure 29. Global Intermediate CDMO Market Share Forecast by Type (2024-2029)
Figure 30. Global Intermediate CDMO Consumption Value Share by Application (2018-2023)
Figure 31. Global Intermediate CDMO Market Share Forecast by Application (2024-2029)
Figure 32. North America Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Intermediate CDMO Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Intermediate CDMO Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. France Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Intermediate CDMO Consumption Value Market Share by Region (2018-2029)
Figure 49. China Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. India Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Intermediate CDMO Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Intermediate CDMO Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 66. Intermediate CDMO Market Drivers
Figure 67. Intermediate CDMO Market Restraints
Figure 68. Intermediate CDMO Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Intermediate CDMO in 2022
Figure 71. Manufacturing Process Analysis of Intermediate CDMO
Figure 72. Intermediate CDMO Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
s
Figure 1. Intermediate CDMO Picture
Figure 2. Global Intermediate CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Intermediate CDMO Consumption Value Market Share by Type in 2022
Figure 4. Antibiotic Intermediates
Figure 5. Antipyretic and Analgesic Intermediate
Figure 6. Cardiovascular System Drug Intermediates
Figure 7. Anticancer Drug Intermediates
Figure 8. Global Intermediate CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Intermediate CDMO Consumption Value Market Share by Application in 2022
Figure 10. Pharmaceutical Company Picture
Figure 11. Biotechnology Company Picture
Figure 12. Generic Company Picture
Figure 13. Others Picture
Figure 14. Global Intermediate CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Intermediate CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Intermediate CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Intermediate CDMO Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Intermediate CDMO Consumption Value Market Share by Region in 2022
Figure 19. North America Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Intermediate CDMO Revenue Share by Players in 2022
Figure 25. Intermediate CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Intermediate CDMO Market Share in 2022
Figure 27. Global Top 6 Players Intermediate CDMO Market Share in 2022
Figure 28. Global Intermediate CDMO Consumption Value Share by Type (2018-2023)
Figure 29. Global Intermediate CDMO Market Share Forecast by Type (2024-2029)
Figure 30. Global Intermediate CDMO Consumption Value Share by Application (2018-2023)
Figure 31. Global Intermediate CDMO Market Share Forecast by Application (2024-2029)
Figure 32. North America Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Intermediate CDMO Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Intermediate CDMO Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. France Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Intermediate CDMO Consumption Value Market Share by Region (2018-2029)
Figure 49. China Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. India Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Intermediate CDMO Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Intermediate CDMO Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Intermediate CDMO Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Intermediate CDMO Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 66. Intermediate CDMO Market Drivers
Figure 67. Intermediate CDMO Market Restraints
Figure 68. Intermediate CDMO Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Intermediate CDMO in 2022
Figure 71. Manufacturing Process Analysis of Intermediate CDMO
Figure 72. Intermediate CDMO Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
